|
|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 61 - 90 of 334 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
|
|
European Medicines Agency's website:
Darunavir Krka d.d. - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Darunavir Medical Valley 600 mg tabletti, kalvopäällysteinen SPC 2024-02-29
|
|
PL
|
Resepti
|
Darunavir Medical Valley 800 mg tabletti, kalvopäällysteinen SPC 2024-02-29
|
|
PL
|
Resepti
|
Darunavir Sandoz 600 mg tabletti, kalvopäällysteinen SPC 2023-07-12
|
|
PL
|
Resepti
|
Darunavir Sandoz 800 mg tabletti, kalvopäällysteinen SPC 2023-07-12
|
|
PL
|
Resepti
|
Darunavir STADA 600 mg tabletti, kalvopäällysteinen SPC 2023-10-24
|
|
PL
|
Resepti
|
Darunavir STADA 800 mg tabletti, kalvopäällysteinen SPC 2023-10-24
|
|
|
|
European Medicines Agency's website:
Darunavir Viatris (ent. Darunavir Mylan) - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Darzalex - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Dasatinib Accord - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Dasatinib Accord Healthcare - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Dasatinib Accordpharma - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Dasatinib Avansor 50 mg tabletti, kalvopäällysteinen SPC 2024-02-02
|
|
PL
|
Resepti
|
Dasatinib Krka 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, 140 mg tabletti, kalvopäällysteinen SPC 2023-04-12
|
|
PL
|
Resepti
|
Dasatinib Sandoz 20 mg, 50 mg, 70 mg, tabletti, kalvopäällysteinen SPC 2023-03-16
|
|
PL
|
Resepti
|
Dasatinib Stada tabletti, kalvopäällysteinen 20 mg, 50 mg, 70 mg, 80 mg, 100mg,140 mg SPC 2024-04-24
|
|
PL
|
Resepti
|
Dasatinib Viatris 20 mg, 50 mg, 70 mg, 100 mg tabletti, kalvopäällysteinen SPC 2023-10-26
|
|
PL
|
Itsehoito
|
Dasergin 5 mg tabletti, kalvopäällysteinen SPC 2024-07-12
|
|
|
|
European Medicines Agency's website:
Dasselta - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
DaTSCAN - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Daurismo - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Daxas - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Daylette 0,02 mg-3 mg tabletti, kalvopäällysteinen SPC 203-01-30
|
|
PL
|
Resepti
|
Deca-Durabolin 50 mg-ml injektioneste, liuos SPC 2023-05-31
|
|
|
|
European Medicines Agency's website:
Dectova - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Deferasirox Accord - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Deferasirox Glenmark 90 mg, 180 mg, 360 mg tabletti, kalvopäällysteinen SPC 2023-04-26
|
|
|
|
European Medicines Agency's website:
Deferasirox Mylan - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Deferasirox Orifarm 90 mg, 180 mg, 360 mg kalvopäällysteiset tabletit, SPC 2023-01-18
|
|
PL
|
Resepti
|
Deferasirox Stada 90 mg, 180 mg, 360 mg kalvopäällysteinen tabletti, SPC 2024-05-28
|
|
|
| |
